Summit Therapeutics Inc. (SMMT)
Market Closed
3 Jun, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary 
XMEX $
15. 07
+0.21
+1.41%
$
13.46B Market Cap
- P/E Ratio
- Div Yield
4,346,224 Volume
0 Eps
$ 14.86
Previous Close 
Want to track SMMT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | 3.01 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
SMMT Earnings Reports FAQ
What is the earnings per share (EPS) for SMMT?
The current EPS is 0.
What is the company's earnings growth rate?
Summit Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Summit Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Summit Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for SMMT at this time, as Summit Therapeutics Inc has no recent EPS data to calculate it.
